Sexual health · Menopause
How to increase libido in women: what actually works in menopause
Female libido drops in perimenopause and menopause because testosterone falls, estrogen drops, and vaginal tissue thins. Once you know the driver, real fixes exist — most of them medical, not psychological.
Why libido drops in midlife
- Testosterone decline — female T falls 50% from age 20 to 40.
- Estrogen loss — thins vaginal tissue, causes pain with sex.
- Sleep debt and cortisol — anti-libido physiology.
- SSRI antidepressants — a common but treatable cause.
What actually works
- Testosterone replacement — see testosterone for women.
- Vaginal estrogen — cream, tablet, or ring. See vaginal estrogen tablet.
- PT-141 — see PT-141 guide.
- Sleep repair — treat night sweats, cap alcohol.
- Review SSRIs with your prescriber if timing lines up.
Frequently asked questions
What raises female libido the fastest?
Physiologic testosterone replacement (topical cream 4-6 mg/day for women) plus vaginal estrogen for tissue health tends to produce noticeable change in 6-8 weeks. PT-141 works acutely on demand.
Does HRT increase libido?
Estrogen alone rarely does. Adding low-dose testosterone typically restores desire, arousal, and orgasm quality. Vaginal estrogen removes pain-driven avoidance.
Is testosterone safe for women?
Yes at physiologic doses (goal: high-normal female range). Compounded topical testosterone or Androfeme (Australia) is standard; oral is not recommended.
What is PT-141 for libido?
PT-141 (bremelanotide) is an FDA-approved (as Vyleesi) subcutaneous peptide that acts on brain melanocortin receptors. Injected 45 minutes before intimacy, it raises arousal in most women.
Do libido supplements work?
Modest at best. Maca, tribulus, and ashwagandha have small effects. Nothing OTC matches testosterone or PT-141.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.